The latest news articles published are shown below. View all published news articles here.
Data entry option for antidote of dabigatran is now available in the SITS registry
SITS registry improves the standard protocols. New data variables about antidote for dabigatran, reason for unknown time of stroke onset and more are now availableRead more
SITS (Safe Implementation of Treatments in Stroke) is a non-profit, research-driven, independent, international collaboration, with its base at the Karolinska Institute in Sweden. SITS is an initiative by the medical profession to provide safe implementation of stroke treatment in routine clinical practice. SITS vision is to reduce the global burden of stroke; by improving the stroke outcome, preventing recurrent stroke and find the best treatments. This will help the authorities to monitor new treatments and set new guidelines. This will also increase the quality of life for stroke patients and save lives.
SITS provides an international network for stroke professionals. The network and the registry benefit all key participants. This includes patients, researchers, participating clinics, nations, regions, regulatory bodies and pharmaceutical companies. The network currently consists of over 3000 stroke professionals in over 70 countries. By being a member of the network you have access to internationally renowned researchers and have the opportunity to be part of high-impact studies. Also regional networks strengthen research within their region.
SITS offers a world-leading platform for high quality stroke data. The platform is an internet-based interactive stroke registry, which serves as a tool for structured data entry and is an instrument for stroke centres to compare their own treatment results with national and global performance. The registry is free to use and has several interactive data entry forms such as IV Thrombolysis, Thrombectomy, Atrial fibrillation, and General stroke registry.
SITS studies have generate more than fifty publications in international peer reviewed journals over the last years and many of these are in high impact journals, e.g. the Lancet, the Lancet Neurology, BMJ, Ann Neurology, Neurology and Stroke. These publications have had an impact on clinical practice such as extending time window for iv thrombolysis and iv thrombolysis for elderly 80 years.
The latest events are shown below. View all events here.